Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.

Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.
复制标题

DOI:
10.2337/dc10-2411
复制
发表时间:
2011-09
期刊:
影响因子:
16.2
通讯作者:
Amiel SA
Amiel SA
中科院分区:
医学1区
文献类型:
--
作者:
Choudhary P;Shin J;Wang Y;Evans ML;Hammond PJ;Kerr D;Shaw JA;Pickup JC;Amiel SA

文献摘要

参考文献

被引文献

相似文献

评价具有低血糖暂停(LGS)功能的探头增强胰岛素泵,该功能可在探头检测到低血糖时自动暂停基础胰岛素输注长达2小时。Paradigm Veo胰岛素泵(Medtronic,Inc.,Northridge,CA)在31名1型糖尿病成人中进行了为期3周的测试。有166次LGS发作:66%的日间LGS发作在10 min内终止,20次发作持续最长2 h。在基线时夜间低血糖最高四分位数的患者中,LGS使用与夜间持续时间缩短≤2.2 mmol/L相关(中位46.2 vs. 1.8 min/d,P = 0.02 [LGS-关闭vs. LGS-开启])。2小时LGS后的中位探头葡萄糖为3.9 mmol/L,基础重新开始后2小时为8.2 mmol/L。在最高风险人群中,使用胰岛素泵和LGS与降低夜间低血糖相关,并被患者广泛接受。
To evaluate a sensor-augmented insulin pump with a low glucose suspend (LGS) feature that automatically suspends basal insulin delivery for up to 2 h in response to sensor-detected hypoglycemia. The LGS feature of the Paradigm Veo insulin pump (Medtronic, Inc., Northridge, CA) was tested for 3 weeks in 31 adults with type 1 diabetes. There were 166 episodes of LGS: 66% of daytime LGS episodes were terminated within 10 min, and 20 episodes lasted the maximum 2 h. LGS use was associated with reduced nocturnal duration ≤2.2 mmol/L in those in the highest quartile of nocturnal hypoglycemia at baseline (median 46.2 vs. 1.8 min/day, P = 0.02 [LGS-OFF vs. LGS-ON]). Median sensor glucose was 3.9 mmol/L after 2-h LGS and 8.2 mmol/L at 2 h after basal restart. Use of an insulin pump with LGS was associated with reduced nocturnal hypoglycemia in those at greatest risk and was well accepted by patients.
DOI: 10.1056/nejm199806043382303
发表时间: 1998-06-04
影响因子: 158.5
作者:
Jones, TW;Porter, P;Tamborlane, WV
通讯作者: Tamborlane, WV
DOI: 10.1007/s00125-009-1365-0
发表时间: 2009-07-01
期刊: DIABETOLOGIA
影响因子: 8.2
作者:
O'Connell, M. A.;Donath, S.;Cameron, F. J.
通讯作者: Cameron, F. J.
DOI: 10.1056/nejmoa0805017
发表时间: 2008-10-02
影响因子: 158.5
作者:
Tamborlane, William V.;Beck, Roy W.;Xing, Dongyuan
通讯作者: Xing, Dongyuan
DOI: 10.2337/dc09-0750
发表时间: 2009-12
期刊: Diabetes care
影响因子: 16.2
作者:
Raccah D;Sulmont V;Reznik Y;Guerci B;Renard E;Hanaire H;Jeandidier N;Nicolino M
通讯作者: Nicolino M